Home / Resources / Clinical Trial Disclosure Noncompliance: What Is Its Impact on Pharma M&As?
WHITE PAPER | OCT 07, 2025

Clinical Trial Disclosure Noncompliance: What Is Its Impact on Pharma M&As?

What are the noncompliance red flags companies should be aware of prior to entering into an M&A deal? What steps should companies take during the due diligence process to protect themselves?

Download to learn more.

PDF preview of Clinical Trial Disclosure Noncompliance: What Is Its Impact on Pharma M&As? white paper, available for download.
Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.
It breaks the trust within the patient community if a company is hiding the results of a trial, or maybe hiding information related to the trial.
Sahil Khatter, Principal Project Manager, Citeline
Related products
Professionals accessing TrialScope Disclose to track trial compliancy and awareness of regulations.
TrialScope Disclose
Manage the complexity of clinical trial disclosure and the risk of non-compliance by automating data entry and reporting to registries
Sponsors accessing TrialScope Intelligence for regulations and requirements.
TrialScope Intelligence
A centralized, interactive repository of the critical regulatory knowledge needed for global clinical trial disclosure compliance
Citeline professionals providing hands on disclosure services.
TrialScope Disclosure Services
Hands-on clinical trial disclosure services, from regulatory writing to registration to results

Related resources

''
DEC 01, 2024
eBook
Regulatory & Compliance

Citeline Maturity Model for Clinical Trial Disclosure

The Citeline Maturity Model for Clinical Trial Disclosure is critical with expanding disclosure requirements and increasing demand trial transparency.

''
APR 08, 2025
White paper
Regulatory & Compliance

Build vs. Buy: Choosing the Right Approach to Clinical Trial Disclosure

As global clinical trial transparency requirements evolve, sponsors must decide whether to build a disclosure management system or buy a vendor solution.

''
APR 14, 2025
Product Information
Regulatory & Compliance

Get the Answers You Need Faster – A Guide to Citeline Regulatory Solutions

Clinical trial disclosure can be a heavy burden for biopharma. This guide provides an overview of how Citeline helps throughout the regulatory process.

View all